CoChat
Sign Up
Cited by 6

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

RETRACTED ARTICLE: The myocardial infarction-associated transcript 2 inhibits lipid accumulation and promotes cholesterol efflux in oxidized low-density lipoprotein-induced THP-1-derived macrophages via inhibiting mitogen-activated protein kinase signaling and activating the nuclear factor erythroid-related factor 2 signaling pathway

Mu, Fangxiang, Wang, Yuqing, Wu, Hong, You, Qingxia, Zhang, Daimin·2022·Bioengineered
DOI 10.1080/21655979.2021.2005932PMC PMC8805865
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/21655979.2021.2005932This paper is marked retracted.

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 1 references

Research works printed but not linked: 34

  1. [1]Mineo C. Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis. Curr Rheumatol Rep. 2013; 15(5): 324. 23519891 PMC3625922
  2. [2]Xu H, Jiang J, Chen W, et al. Vascular macrophages in atherosclerosis. J Immunol Res. 2019; 2019: 4354786. 31886303 PMC6914912
  3. [3]Barrett TJ. Macrophages in atherosclerosis regression. Arterioscler Thromb Vasc Biol. 2020; 40(1): 20– 33. 31722535 PMC6946104
  4. [4]Cochain C, Zernecke A. Macrophages in vascular inflammation and atherosclerosis. Pflugers Arch. 2017; 469(3–4): 485– 499. 28168325
  5. [5]Chistiakov DA, Bobryshev YV, Orekhov AN. Macrophage-mediated cholesterol handling in atherosclerosis. J Cell Mol Med. 2016; 20(1): 17– 28. 26493158 PMC4717859
  6. [6]Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol. 2010; 30(2): 139– 143. 19797709 PMC2812788
  7. [7]Calkin AC, Tontonoz P. Liver x receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010; 30(8): 1513– 1518. 20631351 PMC2919217
  8. [8]Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009; 136(4): 629– 641. 19239885
  9. [9]Zheng J, Huang X, Tan W, et al. Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. Nat Genet. 2016; 48(7): 747– 757. 27213290
  10. [10]Sanchez Calle A, Kawamura Y, Yamamoto Y, et al. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018; 109(7): 2093– 2100. 29774630 PMC6029823
  11. [11]Chi Y, Wang J, Wang J, et al. Long non-coding RNA in the pathogenesis of cancers. Cells. 2019; 8(9): 9. PMC6770362 31480503
  12. [12]Du M, Yuan L, Tan X, et al. The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation. Nat Commun. 2017; 8(1): 2049. 29230038 PMC5725456
  13. [13]Zhang B, Li H, Li D, et al. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p. Gene. 2019; 700: 139– 148. 30898698
  14. [14]Bai C, Nie N, Li Y, et al. Long noncoding RNA Mirt2 prohibits lipopolysaccharide-evoked HK-2 cell injury via modulation of microRNA-126. Biofactors. 2019; 46(3): 465–474. 31889348
  15. [15]Tanaka Y, Aleksunes LM, Yeager RL, et al. NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J Pharmacol Exp Ther. 2008; 325(2): 655– 664. 18281592
  16. [16]Kobayashi EH, Suzuki T, Funayama R, et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun. 2016; 7(1): 11624. 27211851 PMC4879264
  17. [17]Yang S, Zheng Y, Hou X. Lipoxin A4 restores oxidative stress-induced vascular endothelial cell injury and thrombosis-related factor expression by its receptor-mediated activation of Nrf2-HO-1 axis. Cell Signal. 2019; 60: 146– 153. 31059786
  18. [18]Ha SH, Choi H, Park JY, et al. Mycobacterium tuberculosis-secreted protein, ESAT-6, inhibits lipopolysaccharide-induced MMP-9 expression and inflammation through NF-kappaB and MAPK signaling in RAW 264.7 macrophage cells. Inflammation. 2020; 43(1): 54– 65. 31720987
  19. [19]Alam MB, Chowdhury NS, Sohrab MH, et al. Cerevisterol alleviates inflammation via suppression of MAPK/NF-kappaB/AP-1 and activation of the Nrf2/HO-1 signaling cascade. Biomolecules. 2020; 10(2): 2. PMC7072429 32013140
  20. [20]Li ST, Dai Q, Zhang SX, et al. Ulinastatin attenuates LPS-induced inflammation in mouse macrophage RAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway. Acta Pharmacol Sin. 2018; 39(8): 1294– 1304. 29323338 PMC6289329
  21. [21]Flaherty RA, Borges EC, Sutton JA, et al. Genetically distinct Group B Streptococcus strains induce varying macrophage cytokine responses. PloS One. 2019; 14(9): e0222910. 31536604 PMC6752832
  22. [22]Wang G, Bai X, Jiang G, et al. GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. Bioengineered. 2021; 12(1): 30– 43. 33258389 PMC8806235
  23. [23]Shang J, Sun S, Zhang L, et al. miR-211 alleviates ischaemia/reperfusion-induced kidney injury by targeting TGFβR2/TGF-β/SMAD3 pathway. Bioengineered. 2020; 11(1): 547– 557. 32375588 PMC8291827
  24. [24]Han B, Ge Y, Cui J, et al. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis. Bioengineered. 2020; 11(1): 524– 535. 32352854 PMC7202691
  25. [25]Watterson S, Guerriero ML, Blanc M, et al. A model of flux regulation in the cholesterol biosynthesis pathway: immune mediated graduated flux reduction versus statin-like led stepped flux reduction. Biochimie. 2013; 95(3): 613– 621. 22664637 PMC3585962
  26. [26]Wang S, Li P, Jiang G, et al. Long non-coding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal. Bioengineered. 2020; 11(1): 718– 728. 32619136 PMC8291892
  27. [27]Zangrando J, Zhang L, Vausort M, et al. Identification of candidate long non-coding RNAs in response to myocardial infarction. BMC Genomics. 2014; 15(1): 460. 24917243 PMC4070571
  28. [28]Koelwyn GJ, Corr EM, Erbay E, et al. Regulation of macrophage immunometabolism in atherosclerosis. Nat Immunol. 2018; 19(6): 526– 537. 29777212 PMC6314674
  29. [29]Tabas I, Bornfeldt KE. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 2016; 118(4): 653– 667. 26892964 PMC4762068
  30. [30]Huang K, Du M, Tan X, et al. PARP1-mediated PPARalpha poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease. J Hepatol. 2017; 66(5): 962– 977. 27979751 PMC9289820
  31. [31]Mimura J, Itoh K. Role of Nrf2 in the pathogenesis of atherosclerosis. Free Radic Biol Med. 2015; 88(PtB): 221– 232. 26117321
  32. [32]Satta S, Mahmoud AM, Wilkinson FL, et al. The Role of Nrf2 in cardiovascular function and disease. Oxid Med Cell Longev. 2017; 2017: 9237263. 29104732 PMC5618775
  33. [34]Reustle A, Torzewski M. Role of p38 MAPK in atherosclerosis and aortic valve sclerosis. Int J Mol Sci. 2018; 19(12): 12. PMC6321637 30486366
  34. [35]Pan JX. LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway. Eur Rev Med Pharmacol Sci. 2017; 21(2): 322– 328. 28165553

Cited by

Sorted by citations

See all 6

Metadata

Authors
Mu, F., Wang, Y., Wu, H., You, Q., & Zhang, D.
Affiliations
  • The First Affiliated Hospital of Chongqing Medical University
  • Second Affiliated Hospital of Army Medical University
  • Southwest Hospital, Army Medical University
  • Nanjing First Hospital, Nanjing Medical University
Venue
Bioengineered
Publisher
Informa UK Limited
Published
2021-12-29
Volume
13
Issue
1
Pages
407-417
ISSN
  • 2165-5979
  • 2165-5987
DOI
10.1080/21655979.2021.2005932
PMC
PMC8805865
Cited by
6
References
1
Language
en
Status
Retracted
Update notices
Licence
Funders
associated with the work featured

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review